This effect was achieved by silencing TRPC4 in the DRG and showed an effective reduction in psoriatic pruritus even after repeated applications of IMQ.354 Therefore, TRPC4 antagonists may soon be used clinically for the treatment of acute pruritus and psoriasis. The gene discussed is TRPC4; the disease is psoriasis.